Pfizer CFO Says Co Is Close To Presenting Data On Its Oral Weight Loss Drug As Previously Expected, Likely By The End Of The Year.
Pfizer CFO Says Co Is Close To Presenting Data On Its Oral Weight Loss Drug As Previously Expected, Likely By The End Of The Year.